# Establishes "The Equity in Fertility Treatment Act"; relates to the definition of infertility and health insurance coverage for the treatment of infertility

**Bill ID:** A6177A
**Session:** 2024
**Sponsor:** Amy Paulin
**Status:** In Assembly Committee
**PDF:** [A6177A PDF](https://legislation.nysenate.gov/pdf/bills/2024/A6177A)

## Summary

Establishes "The Equity in Fertility Treatment Act"; relates to the definition of infertility and health insurance coverage for the treatment of infertility.

---

## Full Text

S T A T E  O F  N E W  Y O R K
 ________________________________________________________________________
 
  6177
 
  2023-2024 Regular Sessions
 
  I N  A S S E M B L Y
 
  April 3, 2023
  ___________
 
 Introduced  by  M.  of  A.  PAULIN,  BURDICK,  DINOWITZ, GONZALEZ-ROJAS,
  SEAWRIGHT, SILLITTI, SIMONE -- read once and referred to the Committee
  on Insurance
 
 AN ACT to amend the insurance law, in  relation  to  the  definition  of
  infertility and health insurance coverage for in-vitro fertilization

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
  Section 1. This act shall be known and may be cited as "The Equity  in
 Fertility Treatment Act".
  ยง  2.  Items  (v)  and  (vii)  of  subparagraph  (C) of paragraph 6 of
 subsection (k) of section 3221 of  the  insurance  law,  as  amended  by
 section  1  of  part L of chapter 57 of the laws of 2019, are amended to
 read as follows:
  (v)(I) For the purposes  of  this  paragraph,  "infertility"  means  a
 disease  or  condition  characterized  by  the  incapacity to impregnate
 another person or to conceive, defined by (A) the failure to establish a
 clinical pregnancy after twelve months of  regular,  unprotected  sexual
 intercourse  or  therapeutic  donor insemination, or after six months of
 regular, unprotected sexual intercourse or therapeutic  donor  insemina-
 tion  for  a  female  thirty-five  years of age or older; (B) A PERSON'S
 INABILITY TO REPRODUCE EITHER AS A SINGLE INDIVIDUAL OR WITH THEIR PART-
 NER WITHOUT MEDICAL INTERVENTION;  OR  (C)  A  LICENSED  PHYSICIAN'S  OR
 OSTEOPATHIC  PHYSICIAN'S  FINDINGS BASED ON A PATIENT'S MEDICAL, SEXUAL,
 OR REPRODUCTIVE HISTORY, AGE, PHYSICAL FINDINGS, OR DIAGNOSTIC  TESTING.
 Earlier  evaluation  and treatment may be warranted based on an individ-
 ual's medical, SEXUAL, OR REPRODUCTIVE history [or], AGE, physical find-
 ings, OR DIAGNOSTIC TESTING.
  (II) For purposes of this paragraph, "iatrogenic infertility" means an
 impairment of fertility by surgery,  radiation,  chemotherapy  or  other
 medical treatment affecting reproductive organs or processes.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
  [ ] is old law to be omitted.
  LBD10106-02-3
 A. 6177  2
 
  (vii)  Every  large  group  policy delivered or issued for delivery in
 this state that provides medical, major medical  or  similar  comprehen-
 sive-type  coverage  shall  provide  coverage  for  three  [cycles  of]
 COMPLETED OOCYTE RETRIEVALS AND  in-vitro  fertilization  [used  in  the
 treatment  of infertility] WITH UNLIMITED EMBRYO TRANSFERS FROM FRESH OR
 FROZEN OOCYTES OR EMBRYOS FROM A COVERED RETRIEVAL, IN  ACCORDANCE  WITH
 THE  GUIDELINES OF THE AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE, USING
 SINGLE EMBRYO TRANSFER (SET) WHEN RECOMMENDED AND MEDICALLY  APPROPRIATE
 FOR  THE  TREATMENT  OF  INFERTILITY.  Coverage may be subject to annual
 deductibles and coinsurance, including  copayments,  as  may  be  deemed
 appropriate  by  the  superintendent  and  as  are consistent with those
 established for other benefits within a given policy. [For  purposes  of
 this  item,  a  "cycle"  is  defined as either all treatment that starts
 when: preparatory medications are administered for  ovarian  stimulation
 for  oocyte  retrieval with the intent of undergoing in-vitro fertiliza-
 tion using a fresh embryo transfer; or medications are administered  for
 endometrial  preparation with the intent of undergoing in-vitro fertili-
 zation using a frozen embryo transfer.]
  ยง 3. Subparagraphs (E) and (G) of paragraph 3  of  subsection  (s)  of
 section  4303 of the insurance law, as amended by section 2 of part L of
 chapter 57 of the laws of 2019, are amended to read as follows:
  (E)(i) For the purposes of  this  subsection,  "infertility"  means  a
 disease  or  condition  characterized  by  the  incapacity to impregnate
 another person or to conceive, defined by (A) the failure to establish a
 clinical pregnancy after twelve months of  regular,  unprotected  sexual
 intercourse  or  therapeutic  donor insemination, or after six months of
 regular, unprotected sexual intercourse or therapeutic  donor  insemina-
 tion  for  a  female  thirty-five  years of age or older; (B) A PERSON'S
 INABILITY TO REPRODUCE EITHER AS A SINGLE INDIVIDUAL OR WITH THEIR PART-
 NER WITHOUT MEDICAL INTERVENTION;  OR  (C)  A  LICENSED  PHYSICIAN'S  OR
 OSTEOPATHIC  PHYSICIAN'S  FINDINGS BASED ON A PATIENT'S MEDICAL, SEXUAL,
 OR REPRODUCTIVE HISTORY, AGE, PHYSICAL FINDINGS, OR DIAGNOSTIC  TESTING.
 Earlier  evaluation  and treatment may be warranted based on an individ-
 ual's medical history or physical findings.
  (ii) For purposes of this subsection, "iatrogenic  infertility"  means
 an  impairment of fertility by surgery, radiation, chemotherapy or other
 medical treatment affecting reproductive organs or processes.
  (G) Every large group contract that provides medical, major medical or
 similar comprehensive-type coverage shall  provide  coverage  for  three
 [cycles of] COMPLETED OOCYTE RETRIEVALS AND in-vitro fertilization [used
 in  the  treatment  of infertility] WITH UNLIMITED EMBRYO TRANSFERS FROM
 FRESH OR FROZEN OOCYTES OR EMBRYOS FROM A COVERED RETRIEVAL, IN  ACCORD-
 ANCE  WITH THE GUIDELINES OF THE AMERICAN SOCIETY FOR REPRODUCTIVE MEDI-
 CINE, USING SINGLE EMBRYO TRANSFER (SET) WHEN RECOMMENDED AND  MEDICALLY
 APPROPRIATE  FOR  THE TREATMENT OF INFERTILITY.  Coverage may be subject
 to annual deductibles and coinsurance, including copayments, as  may  be
 deemed  appropriate  by  the  superintendent  and as are consistent with
 those established for other  benefits  within  a  given  contract.  [For
 purposes of this subparagraph, a "cycle" is defined as either all treat-
 ment  that  starts  when:  preparatory  medications are administered for
 ovarian stimulation for oocyte retrieval with the intent  of  undergoing
 in-vitro fertilization using a fresh embryo transfer; or medications are
 administered  for  endometrial preparation with the intent of undergoing
 in-vitro fertilization using a frozen embryo transfer.]
  ยง 4. This act shall take effect immediately.